Latest Insider Transactions at Sleep Number Corp (SNBR)
This section provides a real-time view of insider transactions for Sleep Number Corp (SNBR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Sleep Number Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Sleep Number Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 29
2022
|
Joseph Hunter Saklad EVP, Chief Supply Chain Office |
SELL
Payment of exercise price or tax liability
|
Direct |
2,872
-5.67%
|
$157,960
$55.54 P/Share
|
|
Mar 29
2022
|
Joseph Hunter Saklad EVP, Chief Supply Chain Office |
BUY
Grant, award, or other acquisition
|
Direct |
9,383
+15.63%
|
-
|
|
Mar 29
2022
|
Robert Joseph Poirier VP, CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
874
-24.12%
|
$48,070
$55.54 P/Share
|
|
Mar 29
2022
|
Robert Joseph Poirier VP, CAO |
BUY
Grant, award, or other acquisition
|
Direct |
1,613
+30.8%
|
-
|
|
Mar 21
2022
|
David R Callen EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,117
-13.96%
|
$373,137
$61.98 P/Share
|
|
Mar 15
2022
|
Robert Joseph Poirier VP, CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
65
-3.13%
|
$3,965
$61.66 P/Share
|
|
Mar 15
2022
|
Kevin Kennedy Brown EVP and CMO |
SELL
Discretionary transaction
|
Indirect |
3
-0.45%
|
$189
$63.47 P/Share
|
|
Mar 15
2022
|
David R Callen EVP & CFO |
SELL
Discretionary transaction
|
Indirect |
18
-0.61%
|
$1,134
$63.47 P/Share
|
|
Mar 15
2022
|
Samuel R Hellfeld EVP Chief Legal & Risk Officer |
SELL
Discretionary transaction
|
Indirect |
21
-0.49%
|
$1,323
$63.47 P/Share
|
|
Mar 15
2022
|
Shelly Radue Ibach President and CEO |
SELL
Discretionary transaction
|
Indirect |
19
-0.12%
|
$1,197
$63.47 P/Share
|
|
Mar 15
2022
|
Christopher D Krusmark EVP & Chief H.R. Officer |
SELL
Discretionary transaction
|
Indirect |
3
-0.23%
|
$189
$63.47 P/Share
|
|
Mar 10
2022
|
Daniel Alegre Director |
BUY
Grant, award, or other acquisition
|
Direct |
339
+2.69%
|
$21,018
$62.55 P/Share
|
|
Mar 10
2022
|
Deborah L. Kilpatrick Director |
BUY
Bona fide gift
|
Indirect |
339
+2.97%
|
-
|
|
Mar 10
2022
|
Deborah L. Kilpatrick Director |
SELL
Bona fide gift
|
Direct |
339
-29.25%
|
-
|
|
Mar 10
2022
|
Deborah L. Kilpatrick Director |
BUY
Grant, award, or other acquisition
|
Direct |
339
+22.63%
|
$21,018
$62.55 P/Share
|
|
Mar 01
2022
|
Shelly Radue Ibach President and CEO |
BUY
Bona fide gift
|
Indirect |
6,000
+3.54%
|
-
|
|
Mar 01
2022
|
Shelly Radue Ibach President and CEO |
SELL
Bona fide gift
|
Direct |
6,000
-6.38%
|
-
|
|
Mar 01
2022
|
Shelly Radue Ibach President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,120
-11.42%
|
$751,440
$62.2 P/Share
|
|
Mar 01
2022
|
Shelly Radue Ibach President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,120
+8.17%
|
$471,120
$26.07 P/Share
|
|
Feb 25
2022
|
Brenda J Lauderback Director |
SELL
Open market or private sale
|
Direct |
1,660
-4.51%
|
$104,580
$63.35 P/Share
|
|
Feb 25
2022
|
Brenda J Lauderback Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,499
+6.35%
|
$67,473
$27.45 P/Share
|
|
Feb 25
2022
|
Daniel Alegre Director |
SELL
Open market or private sale
|
Direct |
17,000
-58.8%
|
$1,105,000
$65.89 P/Share
|
|
Feb 25
2022
|
Stephen L Gulis Jr Director |
SELL
Bona fide gift
|
Direct |
950
-3.44%
|
-
|
|
Jan 13
2022
|
Andrea Lee Bloomquist EVP, Chief Innovation Officer |
BUY
Acquisition or disposition by will or laws
|
Indirect |
603
+50.0%
|
-
|
|
Dec 15
2021
|
Daniel Alegre Director |
BUY
Grant, award, or other acquisition
|
Direct |
278
+0.95%
|
$21,128
$76.28 P/Share
|
|
Nov 09
2021
|
Michael J Harrison Director |
BUY
Bona fide gift
|
Indirect |
39,715
+50.0%
|
-
|
|
Nov 09
2021
|
Michael J Harrison Director |
SELL
Bona fide gift
|
Direct |
39,715
-95.34%
|
-
|
|
Nov 05
2021
|
Kathleen L Nedorostek Director |
SELL
Bona fide gift
|
Direct |
4,795
-28.51%
|
-
|
|
Nov 05
2021
|
Kevin Kennedy Brown EVP and CMO |
SELL
Open market or private sale
|
Direct |
16,190
-19.83%
|
$1,440,910
$89.79 P/Share
|
|
Nov 05
2021
|
Kevin Kennedy Brown EVP and CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,190
+16.55%
|
$339,990
$21.21 P/Share
|
|
Nov 04
2021
|
Christopher D Krusmark EVP & Chief H.R. Officer |
SELL
Open market or private sale
|
Direct |
1,705
-14.04%
|
$155,155
$91.0 P/Share
|
|
Nov 04
2021
|
Christopher D Krusmark EVP & Chief H.R. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,705
+12.31%
|
$57,970
$34.35 P/Share
|
|
Nov 03
2021
|
Kevin Kennedy Brown EVP and CMO |
SELL
Bona fide gift
|
Direct |
548
-1.65%
|
-
|
|
Sep 22
2021
|
Daniel Alegre Director |
BUY
Grant, award, or other acquisition
|
Direct |
210
+0.73%
|
$21,210
$101.19 P/Share
|
|
Sep 20
2021
|
Samuel R Hellfeld EVP Chief Legal & Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,324
-29.74%
|
$402,132
$93.93 P/Share
|
|
Sep 20
2021
|
Samuel R Hellfeld EVP Chief Legal & Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,180
+29.83%
|
-
|
|
Jul 23
2021
|
Shelly Radue Ibach President and CEO |
BUY
Bona fide gift
|
Indirect |
3,290
+2.04%
|
-
|
|
Jul 23
2021
|
Shelly Radue Ibach President and CEO |
SELL
Bona fide gift
|
Direct |
3,290
-3.6%
|
-
|
|
Jul 23
2021
|
Shelly Radue Ibach President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,290
+3.48%
|
$108,570
$33.32 P/Share
|
|
Jul 22
2021
|
Shelly Radue Ibach President and CEO |
BUY
Bona fide gift
|
Indirect |
4,820
+3.03%
|
-
|
|
Jul 22
2021
|
Shelly Radue Ibach President and CEO |
SELL
Bona fide gift
|
Direct |
4,820
-5.19%
|
-
|
|
Jul 22
2021
|
Shelly Radue Ibach President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,820
+4.94%
|
$159,060
$33.32 P/Share
|
|
May 25
2021
|
Samuel R Hellfeld EVP Chief Legal & Risk Officer |
BUY
Discretionary transaction
|
Indirect |
1,878
+31.96%
|
$200,946
$107.61 P/Share
|
|
May 25
2021
|
Daniel Alegre Director |
SELL
Open market or private sale
|
Direct |
12,852
-31.14%
|
$1,375,164
$107.55 P/Share
|
|
May 24
2021
|
David R Callen EVP & CFO |
BUY
Discretionary transaction
|
Indirect |
2,947
+50.0%
|
$312,382
$106.11 P/Share
|
|
May 12
2021
|
Daniel Alegre Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,862
+5.88%
|
$438,412
$26.94 P/Share
|
|
May 12
2021
|
Daniel Alegre Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,019
+2.04%
|
$54,007
$53.27 P/Share
|
|
May 12
2021
|
Stephen L Gulis Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
820
+2.89%
|
-
|
|
May 12
2021
|
Michael J Harrison Director |
BUY
Grant, award, or other acquisition
|
Direct |
820
+1.93%
|
-
|
|
May 12
2021
|
Julie Howard Director |
BUY
Grant, award, or other acquisition
|
Direct |
820
+14.32%
|
-
|